NYSE · Price History

Veradermics, Incorporated (MANE) Stock Price History & Returns

$125.64 NYSE: MANE Market Cap $5.30B

Price history through Nov 17, 2026 · Source: Yahoo Finance (adjusted closes) (methodology)

How Veradermics, Incorporated (MANE) has performed, year by year and over each trailing period. Price history only — total return to a shareholder would also include dividends.

The share price of $125.64 sits 75% of the way up a 52-week range of $32.00 to $156.69; 19.8% below the 52-week high; above its 50-day moving average of $119.68; above its 200-day average of $95.40; a beta of 1.23 means it has historically moved more than the market.

Total return

Price change over each trailing period, not annualised.

PeriodReturn
3 months+13.0%
6 months+20.0%

Monthly closing prices

The last 10 months, newest first. 6 of 9 months closed higher than the month before. Each figure is the last close in that month.

MonthCloseChange
November 2026$125.64-10.1%
October 2026$139.69+15.2%
September 2026$121.23+23.2%
August 2026$98.41-6.3%
July 2026$105.00-14.6%
June 2026$122.94+21.8%
May 2026$100.91+1.9%
April 2026$99.00+56.8%
March 2026$63.15+37.7%
February 2026$45.85—

Veradermics, Incorporated (MANE) price history — frequently asked questions

How has Veradermics, Incorporated performed over the last year?

Veradermics, Incorporated (MANE) has risen 0.0% over the last twelve months, measured on price alone.

What is Veradermics, Incorporated's five-year return?

Over five years the MANE share price has gained 0.0%, excluding dividends.

What is Veradermics, Incorporated's 52-week range?

Over the last year Veradermics, Incorporated (MANE) has traded between $32.00 and $156.69.

Price returns of other Biotechnology stocks

VRTX 1-year +22.4%REGN 1-year +38.2%MRNA 1-year +740.3%RVMD 1-year +137.0%ROIV 1-year +92.3%INSM 1-year -36.3%UTHR 1-year +27.9%INCY 1-year +14.8%ALNY 1-year -63.6%ASND 1-year +33.4%All Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.